Core--Clinical trials office
核心--临床试验办公室
基本信息
- 批准号:6396877
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2000-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The primary mission of the Clinical Trials Shared Resource (CTSR) is to assist Cancer Center investigators develop, activate and complete scientifically valid clinical trials in an organized, cost-effective and methodologically sound manner. To enhance the efficiency of clinical trials support staff, all institutional data managers, research nurses and clerical staff engaged in cancer clinical trials activity have been consolidated into a shared resource under the direction of Dr. Barbara Murphy and Ms. Debbie Wujcik, R.N., M.S.N.. This consolidation permits pooling of support dollars as well allowing for maximum utilization of such funding. The CTSR is designed to facilitate investigator- initiated research. The major areas of responsibility of the CTSR include: 1) protocol support services including protocol activation and monitoring, 2) provision of data management services and 3) provision of research nursing support. In order to provide these services in an organized and uniform manner, services have been grouped into three categories: Core Services, Data Management Services, and Research Nursing Services. The CTSR strives to facilitate scientifically sound research programs in specific areas of investigation. This is accomplished through disease-specific and modality-specific research teams which consist of physician investigators, data managers, nurses and associated staff with an interest in specific malignancy or category of malignancies (e.g. thoracic oncology). Research teams are responsible for: 1) protocol review and program development; 2) protocol activation through the IRB and scientific review committees; 3) identification, consent and registration of eligible patients; 4) data acquisition, data management and quality control; and 5) provision of protocol information to participating VCC investigators. With the assistance of CTSR staff, physician team leaders convene regular meetings during which there is review of protocol accrual information, data management activities and workload and adverse events. In addition, the teams review and evaluate new protocols, set program and study priorities, and make decisions regarding resource allocation.
临床试验共享资源(CTSR)的主要任务是帮助癌症中心的研究人员以有组织、有成本效益和方法合理的方式开发、激活和完成科学有效的临床试验。为了提高临床试验支持人员的效率,在Barbara Murphy博士和Debbie Wojcik女士,R.N.,M.S.N.的指导下,所有从事癌症临床试验活动的机构数据经理、研究护士和文书人员被整合为一个共享资源。这种合并还允许汇集支助资金,从而最大限度地利用这种资金。CTSR旨在促进调查人员发起的研究。CTSR的主要职责领域包括:1)协议支持服务,包括协议激活和监测;2)提供数据管理服务;3)提供研究护理支持。为了以有组织和统一的方式提供这些服务,服务被分为三类:核心服务、数据管理服务和研究护理服务。CTSR努力促进在特定调查领域开展科学合理的研究计划。这是通过特定疾病和特定模式的研究团队完成的,研究团队由对特定恶性肿瘤或恶性肿瘤类别(例如胸腔肿瘤学)感兴趣的医生调查人员、数据经理、护士和相关工作人员组成。研究团队负责:1)方案审查和计划开发;2)通过IRB和科学审查委员会激活方案;3)确认、同意和登记符合条件的患者;4)数据获取、数据管理和质量控制;以及5)向参与的VCC调查人员提供方案信息。在CTSR工作人员的协助下,医生团队负责人定期召开会议,在此期间审查方案应计信息、数据管理活动以及工作量和不良事件。此外,这些团队还审查和评估新的协议,设定计划和研究的优先顺序,并就资源分配做出决定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barbara A. Murphy其他文献
Development of a model for inducing transient insulin resistance in the mare: preliminary implications regarding the estrous cycle.
开发用于诱导母马短暂胰岛素抵抗的模型:对发情周期的初步影响。
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:3.3
- 作者:
D. R. Sessions;Stephanie E. Reedy;M. M. Vick;Barbara A. Murphy;B. Fitzgerald - 通讯作者:
B. Fitzgerald
Longitudinal oncology registry of head and neck carcinoma (LORHAN®): initial supportive care findings
头颈癌纵向肿瘤学登记 (LORHAN®):初步支持治疗结果
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:3.1
- 作者:
Barbara A. Murphy;Amy Y. Chen;Walter J. Curran;A. Garden;P. Harari;Stuart J. Wong;K. Ang - 通讯作者:
K. Ang
Oral health in oncology: impact of immunotherapy
- DOI:
10.1007/s00520-014-2434-6 - 发表时间:
2014-09-13 - 期刊:
- 影响因子:3.000
- 作者:
Leanne K. Jackson;Douglas B. Johnson;Jeffrey A. Sosman;Barbara A. Murphy;Joel B. Epstein - 通讯作者:
Joel B. Epstein
Interferon regulatory factor‐1 is a major regulator of epidermal growth factor receptor gene expression
干扰素调节因子-1是表皮生长因子受体基因表达的主要调节因子
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:3.5
- 作者:
Y. Rubinstein;Kimberle N Proctor;M. Bergel;Barbara A. Murphy;A. Johnson - 通讯作者:
A. Johnson
Mobile blue light therapy is as effective as stable lighting at advancing seasonal reproductive activity in mares
- DOI:
10.1016/j.jevs.2013.10.070 - 发表时间:
2014-01-01 - 期刊:
- 影响因子:
- 作者:
Caroline M. Walsh;Elizabeth M. Woodward;Ralph L. Prendergast;James P. Rylei;Luke H. Fallon;Mats H.T. Troedsson;Barbara A. Murphy - 通讯作者:
Barbara A. Murphy
Barbara A. Murphy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barbara A. Murphy', 18)}}的其他基金
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
头颈癌的纤维化-淋巴水肿连续体
- 批准号:
8098131 - 财政年份:2010
- 资助金额:
-- - 项目类别:
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
头颈癌的纤维化-淋巴水肿连续体
- 批准号:
8541621 - 财政年份:2010
- 资助金额:
-- - 项目类别:
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
头颈癌的纤维化-淋巴水肿连续体
- 批准号:
8255582 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Hospice Pain Control: Developing an Opioid Order Sheet
临终关怀疼痛控制:制定阿片类药物订单表
- 批准号:
7121936 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Hospice Pain Control: Developing an Opioid Order Sheet
临终关怀疼痛控制:制定阿片类药物订单表
- 批准号:
6953440 - 财政年份:2005
- 资助金额:
-- - 项目类别:
PHASE I/II AND PHARMACOLOGIC STUDYOF PACLITAXEL GIVEN AS 96 HOUR INFUSION
紫杉醇 96 小时输注的 I/II 期和药理学研究
- 批准号:
6246776 - 财政年份:1997
- 资助金额:
-- - 项目类别:
DOSE RANGING EFFICACY, SAFETY, AND PHARMACOKINETIC STUDY OF RS25259
RS25259 的剂量范围疗效、安全性和药代动力学研究
- 批准号:
5219416 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
-- - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
-- - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
-- - 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
-- - 项目类别: